ORBIMED ADVISORS LLC 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
OA
ORBIMED ADVISORS LLC
Institutional Filer 3.09%$4.75B107

Current Portfolio Holdings

Showing all 107 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1EWTXEdgewise Therapeutics, Inc.Healthcare15.5M$488.8M10.30%
2ELVNEnliven Therapeutics, Inc.Healthcare8.0M$312.0M6.57%
3LLYEli Lilly and CompanyHealthcare237K$217.8M4.59%
4RCELAVITA Medical, Inc.Healthcare82.0M$197.0M4.15%
5SVASINOVAC BIOTECH LTD2.7M$184.5M3.89%
6BSXBoston Scientific CorporationHealthcare2.4M$149.5M3.15%
7SIONSionna Therapeutics, Inc.Healthcare3.5M$141.5M2.98%
8AZNAstraZeneca PLCHealthcare670K$132.2M2.78%
9MYGNMyriad Genetics, Inc.Healthcare125.0M$122.9M2.59%
10MBXMBX Biosciences, Inc. Common StockHealthcare3.6M$108.6M2.29%
11CRVSCorvus Pharmaceuticals, Inc.Healthcare7.2M$104.8M2.21%
12ARGXargenx SEHealthcare137K$100.0M2.11%
13EWEdwards Lifesciences CorporationHealthcare1.2M$98.5M2.08%
14ISRGIntuitive Surgical, Inc.Healthcare209K$96.2M2.03%
15CMPXCompass Therapeutics, Inc.Healthcare15.2M$80.5M1.70%
Showing 1 to 15 of 107 holdings